Enfusion (ENFN)
(Delayed Data from NYSE)
$9.52 USD
+0.01 (0.11%)
Updated May 2, 2024 04:00 PM ET
After-Market: $9.52 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ENFN 9.52 +0.01(0.11%)
Will ENFN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ENFN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENFN
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
ENFN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Box (BOX) Q4 Earnings Beat Estimates
Strength Seen in Phunware (PHUN): Can Its 75.3% Jump Turn into More Strength?
Arteris, Inc. (AIP) Reports Q4 Loss, Tops Revenue Estimates
Other News for ENFN
Notable Two Hundred Day Moving Average Cross - ENFN
Enfusion Announces Date of First Quarter 2024 Results
Piper Sandler Reaffirms Their Hold Rating on Enfusion (ENFN)
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Bullish Two Hundred Day Moving Average Cross - ENFN